Chicago Partners Investment Group’s Acumen Pharmaceuticals ABOS Stock Holding History

Chicago Partners Investment Group’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,958	Closed	-$44.1K	–	744
2024 Q1	$44.1K	Sell	13,958 -4,357	-24%	-$16.4K	﹤0.01%	725
2023 Q4	$59.2K	Buy	18,315 +4,736	+35%	+$14.1K	﹤0.01%	685
2023 Q3	$44.9K	Buy	+13,579	New	+$83.9K	﹤0.01%	644
2023 Q2	–	Sell	-12,332	Closed	-$46.6K	–	684
2023 Q1	$46.6K	Sell	12,332 -6,347	-34%	-$33.1K	﹤0.01%	650
2022 Q4	$109K	Buy	18,679 +7,594	+69%	+$51K	0.01%	615
2022 Q3	$72K	Buy	+11,085	New	+$63.6K	0.01%	570
2022 Q1	–	Sell	-17,960	Closed	-$92K	–	564
2021 Q4	$92K	Buy	17,960 +3,156	+21%	+$34.7K	0.01%	551
2021 Q3	$199K	Buy	+14,804	New	+$246K	0.01%	553

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Chicago Partners Investment Group's ABOS Position: Q2 2024 in Review

Chicago Partners Investment Group sold out of Acumen Pharmaceuticals (ABOS) in Q2 2024, closing a stake of 13,958 shares — an estimated $44.1K sold.

Chicago Partners Investment Group first reported a position in ABOS in Q3 2021 and held it in 8 quarters. The position peaked at $199K in Q3 2021. 81 funds tracked by Wall St. Rank hold ABOS as of Q2 2024.

Chicago Partners Investment Group reported no remaining Acumen Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Chicago Partners Investment Group sold 13,958 Acumen Pharmaceuticals shares in Q2 2024, an estimated $44.1K.
Chicago Partners Investment Group first reported a position in Acumen Pharmaceuticals in Q3 2021 and held it in 8 quarters.
Chicago Partners Investment Group's Acumen Pharmaceuticals position peaked at $199K in Q3 2021.
81 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2024.

Based on Chicago Partners Investment Group's 13F filing for Q2 2024, filed 31 Jul 2024.